Metabolic syndrome in childhood;Síndrome metabólico en la infancia

Anales de Pediatria

Volumn 66, Issue 2, 2007, Pages 159-166

  Tapia Ceballos, L ^a  

^a HOSPITAL COSTA DEL SOL   (Spain)

Author keywords

Insulin resistance; Metabolic syndrome; Obesity

Indexed keywords

ARTERIOSCLEROSIS; ARTICLE; CARDIOVASCULAR DISEASE; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; RISK FACTOR; SPAIN; WORLD HEALTH ORGANIZATION;

EID: 33947371182     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13098934     Document Type: Article

References (76)

1. Reaven G. Banting lecture: Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
2. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. 2002. Report No.: 106.
3. Alberti K, Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.
4. World Health Oganization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Genève: World Health Organization; 1999.
5. Balkau B, Charles M. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442-3.
6. Meigs JB, D'Agostino RB, Wilson PW, Cupples LA, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes. 1997;46:1594-1600.
7. Lee J, Sparrow D, Vokonas P, Landsberg L, Weiss ST. Uric acid coronary heart disease risk: Evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. Am J Epidemiol. 1995;142:288-94.
8. Weiss R, Dziura J, Burgert T, Tamborlane W, Taksali S, Yeckel C, et al. Obesity and the Metabolic Syndrome in Children and Adolescents. N Engl J Med. 2004;350:2362-74.
9. Nygard O, Vollset S, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al. Total homocysteine and cardiovascular disease. J Intern Med. 1999;246:425-54.
10. Hotamiligil G, Spiegelman B. Tumor necrosis factor alpha: A key component of the obesity-diabetes link. Diabetes. 1994;43:1271-8.
11. Campos M, Cañete R, Villada I, Linde J, Ramírez-Tortosa MC, Gil A. Relaciones de la adiponectina con la resistencia insulínica, lípidos plasmaticos y TNF-alfa, en el niño obeso prepúber. An Pediatr. 2004;60 Supl 2:153.
12. Ford E, Giles W, Dietz W. Prevalence of the metabolic syndrome among US adults: Findings from the third National and Nutrition Examination Survey. JAMA. 2002;287:356-9.
13. Ford E, Giles W, Mokdad A. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care. 2004;27:2444-9.
14. Park Y, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB, et al. The metabolic syndrome: Prevalence and associated risk factors findings in the US population from de Third National Health and Nutrition Examination Survey 1988-1994. Arch Intern Med. 2003;163:427-36.
15. Mills GW, Avery P, McCarthy M, Hattersley AT, Levy JC, Hitman GA, et al. Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes. Diabetologia. 2004;47:732-8.
16. Srinivasan S, Myers L, Berenson G. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: The Bogalusa Heart Sudy. Diabetes. 2002;51:204-9.
17. Cruz M, Weigensberg M, Huang T, Ball G, Shaibi G, Goran M. The metabolic syndrome in overweight Hispanic youth and the role on insulin sensitivity. Clin Endocrinol Metab. 2004;89:108-13.
18. Colino E, Peña L, Saavedra P, Quinteiro S, Domínguez A, Ramos JC. Síndrome de insulinorresistencia en niños obesos. An Pediatría. 2003;58 Supl 2:176.
19. García E, Lafuente I, Talavera J, Ramos J, Jiménez- Uría MR, Rodríguez FI. Resistencia insulínica en niños obesos y adolescentes obesos. An Pediatr. 2003; 58 Supl 2:177.
20. Bueno G, Moreno L, Tresaco B, Bueno M, Garagorri J. Análisis clínico-metabólico de la insulinorresistencia en niños y adolescentes obesos. An Pediatr. 2003;5 Supl 2:177.
21. Sinaiko AR, Jacobs DR Jr, Steinberger J, Morán A, Luepker R, Rocchini AP, et al. Insulin resistance syndrome in childhood: Associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. J Pediatr. 2001;139:700-7.
22. Cruz ML, Huang TT, Johnson MS, Gower BA, Goran MI. Insulin sensitivity and blood pressure in black and white children. Hypertension. 2002;40:18-22.
23. Barlow S, Dietz W. Obesity evaluation and treatment: Expert committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration, and the Deparment of Health and Human Services. Pediatrics. 1998;102:E29.
24. Cole T, Bellizi M, Flegal K, Dietz W. Establishing a standard definition for child overweight and obesity worlwide: International survey. BMJ. 2000;320:1240-3.
25. Dobbelsteyn C, Joffres M, MacLean D, Flowerdew G. A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indication of cardiovascular risk factors: The Canadian Health Surveys. Int J Obes Relat Metab Disord. 2001;25:652-61.
26. Janssen I, Heymsfield S, Allison D, Kotler D, Roos R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcuaneous, and visceral fat. Am J Clin Nutr. 2002;75:683-8.
27. Maffeis C, Pietrobelli A, Grezzani A, Provera S, Tato L. Waist circumference and cardiovascular risk factors in prepuberal children. Obes Res. 2001;9:179-87.
28. Savva S, Tornaritis M, Savva M, Kourides Y, Panagi A, Silikiotou N, et al. Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes Relat Metab Disord. 2000;24:1453-8.
29. Moreno LA, Pineda I, Rodríguez G, Fleta J, Sarría A, Bueno M. Waist circumference for the screening of the metabolic syndrome in children. Acta Paediatr. 2002;91:1307-12.
30. Daniels S, Khoury P, Morrison J. Utility of different measures of body fat distribution in childre and adolescents. Am J Epidemiol. 2000;152:1179-84.
31. Curvas de Referencia para la Tipificación Ponderal. Dossier de consenso. Grupo colaborativo AEP-SENC-SEEDO. 2002.
32. Ogden C, Flegal K, Carrol M, Johnson C. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002;288:1728-32.
33. Serra Manjen L, Ribas Barba L, Arancete Bartrina J, Pérez Rodrigo C, Saavedra Santana P, Peña Quintana L. Obesidad infentil y juvenil en España. Resultados del estudio En Kid (1998-2000). Medicina Clínica. 2003;121(19):725-32.
34. Wabitsch M. Overweight and obesity in European children: Definition and diagnosis procedures, risk factors and consequences for later health outcome. Eur J Pediatr. 2000;159 Suppl 1:8-13.
35. McGill H, McMahan C, Herderick E, Zieske AW, Malcom GT, Tracy RE, et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002;105:2712-8.
36. Decsi T, Molnar D. Insulin resistance syndrome in children. Pediatr Drugs. 2003;5:291-9.
37. Bergman R. Toward physiological understanding of glucose tolerance: minimal model approach. Diabetes. 1989;38:1527.
38. Ferannini E, Mari A. How to measure insulin sensitivity. J Hypertens. 1998;16:895-906.
39. De Fronzo R, Tobin J, Andres R. Glucosa clamp technique: A method for the quantification of beta cell sensitivity to glucose and of tissue sensitivity to insulin. Am J Physiol. 1979;237:214-23.
40. Soonthornpun S, Setasuban W, Thamprasit A, Chayanunnukul W. Rattarasarn C, Geater A. Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab. 2003;88:1019-23.
41. Yeckel C, Weiss R, Dziura J, Taksali S, Dufour S, Burgert T, et al. Validation of Insulin Sensitivity Indices from Oral Glucose Tolerance Test Parameters in Obese Children and Adolescents. J Clin Endocrinol Metab. 2004;89:1096-101.
42. Goran M, Gower B. Longitudinal study on pubertal insulin resistance. Diabetes. 2001;50:2444-50.
43. Lambert M, Paradis G, O'Loughlin J, Delvin EE, Hanley JA, Levy E. Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord. 2004;28:833-41.
44. Csabi G, Torok K, Jeges S, Molnar D. Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr. 2000;159:91-4.
45. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: Insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
46. Keskin M, Kurtoglu S, Kendirci M, Atabek M, Yazici M. Homeostasis Model Assessment Is More Reliable Than the Fasting Glucosa/Insulin Ratio and Quantitative Insulin Sensitivity Chack Index for AssessingInsulin Resistance Among Obese Children and Adolescents. Pediatrics. 2005;115:500-3.
47. Reinehr T, Andler W. Changes in the atherogenic risk factos profile according to degree of weight loss. Arch Dis Child. 2004;89:419-22.
48. Allard P, Delvin E, Paradis G, Hanley J, O'Loughlin J, Lavallée C, et al. Distribution of fasting plasma insulin, free fatty acids and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolecents. Clin Chem. 2003;49:644-9.
49. Tresaco B, Bueno G, Pineda I, Moreno LA, Garagorri JM, Bueno M. Homeostatic model assessment (HOMA) index cut-off values to identify the metabolic syndrome in children. J Physiol Biochem. 2005;61:381-8.
50. Shalitin S, Abrahami M, Lilos P, Phillip M. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel. Intern J Obesity. 2005;29:571-8.
51. Mazza C, Ozuna B, Krochik A, Araujo M. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in obese Argentinean children and adolescents. J Pediatr Endocrinol Metab. 2005;18:491-8.
52. Katz A, Nambi S, Mather K, Baron A, Follman D, Sullivan G, et al. Quantitative insulin sensitivity check index: A simple, accurate method for assesing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-10.
53. Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab. 2002;87:144-7.
54. Legro R, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998;83:2698.
55. Dimartino-Nardi J. Premature adrenarche: Findings in prepuberal African-American and Caribbean-Hispanic girls. Acta Paediatr. 1999;433 Suppl:67-72.
56. Cutfield W, Jefferies C, Jackson W, Robinson E, Hofman P. Evaluation of HOMA and QUICKI as measures of insulin sensitivity in prepuberal children. Pediatr Diabetes. 2003;4:115-8.
57. Conwell L, Trost S, Brown W, Batch J. Indexes of insulin resistance and secretion in obese children and adolescents: A validation study. Diabetes Care. 2004;27:314-9.
58. Klein B, Klein R, Lee K. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care. 2002;25:1790-4.
59. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention study. Circulation. 2003;108:414-9.
60. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245-50.
61. Marceau P, Biron S, Hould F, Marceau S, Simard S, Thung SN, et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab. 1999;84:1513-7.
62. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Arch Intern Med. 2004;140:167-74.
63. Ip M, Lam B, Ng M, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165:670-6.
64. Pasquali R, Gambineri A, Anconetani B, Vicennati V, Colitta D, Caramelli E, et al. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term estrogen-progestagen treatment. Clin Endocrinol (Oxf). 1999;50:517-27.
65. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Hams T, Shorr RI, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA. 2004;292:2237-42.
66. Chen W, Bao W, Begum S, Elkasabany A, Srinivasan SR, Berenson GS. Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: The Bogalusa Heart Study. Diabetes. 2000;49:1042-8.
67. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz W. Prevalence of a metabolic syndrome phenotype in adolescents: Findings from the third National Health and Nutrition Examination Survey 1988-1994. Arch Pediatr Adolesc Med. 2003;157:821-7.
68. Viner R, Segal T, Lichtarowicz-Krynska E, Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child. 2005;90:10-4.
69. Raitakari O, Porkka K, Rasanen L, Ronnemaa T, ViiKari J. Clustering and six years cluster-tracking of serum total cholesterol, HDL-cholesterol an diastolic blood pressure in children and young adults. The Cardiovascular Risk in Youngs Finns Study. J Clin Epidemiol. 1994;47:1085-93.
70. Bao W, Srinivasan S, Wattigney W, Berenson G. Persistence of multiple cardiovascular risk related to syndrome X from childhood to young adulthood. Arch Intern Med. 1994;154:1842-7.
71. Katzmarzyk P, Perusse L, Malina R, Bergeron J, Despres J, Bouchard C. Stability of indicators of metabolic syndrome from chilhood and adolescence to young adult: the Quebec Family Study. J Clin Epidemiol. 2001;54:190-5.
72. The expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2005;28 Suppl 1:37-42.
73. Grupo Colaborativo Español para el estudio de los factores de riesgo cardiovascular en niños y adolescentes. Factores de riesgo cardiovascular en la infancia y adolescencia en España. Estudio RICARDIN. Valores de Referencia. An Esp Pediatr. 1995;43:11-7.
74. Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S. Beneficial effects of metformin in normoglucemic morbidly obese adolescents. Metabolism. 2001;50:1457-61.
75. Miyazeki Y, Mahonkali A, Matsuda M, Mahankali S, Hardies J. Cusi K, et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patient. J Clin Endocrinol Metab. 2002;87:2784-91.
76. Wiegman A, Hutten BA, De Groot E, Rodenburg J, Bakker HD, Buller HR, et al. Efficacy an safety of statin therapy in children with familial hypercholesterolemia: A randomized contolled trial. JAMA. 2004;292:331-7.